Thomas Kelly

Thomas brings to AEGEA a strong combination of management skills in Operations and Quality Assurance gained through 25 years in the medical device industry. Before joining AEGEA he was Vice President of Operations & Quality at ForSight VISION4, a startup company developing an ocular implant to facilitate sustained drug therapy; the company was acquired by Genentech. Prior to ForSight, Thomas served as Vice President of Operations and Quality at Arstasis. He implemented and managed the Operations and Quality functions, growing the femoral access technology from pre-clinical to FDA 510k and CE approval through market launch. At Cierra, Thomas implemented and managed the QA function as Director of Quality Assurance leading to ISO 13485 certification and achievement of the CE Mark for the Patent Foramen Ovale closure device. Thomas worked for Perclose developing arterial closure devices, contributing to the company’s growth from a small, pre-clinical startup to a successful publicly traded company, followed by acquisition into Abbott Laboratories. He contributed in several areas, developing a solid foundation in Quality Assurance, Manufacturing Engineering, and Research and Development. He headed cross-functional product development and manufacturing transfer teams for new products, including integration of an acquired technology, through market launch. Thomas started his medical device career with Stryker Corporation’s Endoscopy division in Quality Assurance. Thomas holds a B.S. in Manufacturing Engineering from Oregon State University.